tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

TECHBio-Techne

Health care · Biotechnology · Nasdaq
Headquarters
Minneapolis, MN
CEO
Kim Kelderman
Next results
around Feb 3, 2027
Compare with peers → Embed

The biggest changes in the 10-K filed 2026-08-24, this fiscal year against the last, and the sentences in the MD&A (Item 7) where management explains them, quoted word for word. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Net income

+147.9% Big change FY to 2026-06-30 vs 2025-06-30

The MD&A has no sentence that names a cause for this change. That can be worth a question: ask about the filing.

Operating margin

8.4% → 20.7% (+12.3 pts) Big change FY to 2026-06-30 vs 2025-06-30

“The decrease in research and development expenses in fiscal 2026 compared to the prior period was primarily attributable to the divestiture of the Exosome Diagnostics business in our Diagnostics and Spatial Biology segment.”

Read it in the 10-K ↗

Gross margin

64.8% → 65.8% (+1.0 pts) FY to 2026-06-30 vs 2025-06-30

“The decrease in the Protein Sciences segment’s gross margin percentage for fiscal 2026 as compared to fiscal 2025 was primarily attributable to unfavorable product mix and pricing pressure within the segment.”

Read it in the 10-K ↗

“The decrease in the Diagnostics and Spatial Biology segment’s gross margin percentage for fiscal 2026 as compared to fiscal 2025 is primarily attributable to unfavorable product mix within the segment.”

Read it in the 10-K ↗

Cash from operations

+1.6% FY to 2026-06-30 vs 2025-06-30

The MD&A has no sentence that names a cause for this change. That can be worth a question: ask about the filing.

Revenue

-0.4% FY to 2026-06-30 vs 2025-06-30

“Organic revenue growth was primarily driven by strong commercial execution in our Protein Sciences segment.”

Read it in the 10-K ↗

“Segment revenue was impacted by the Exosome Diagnostics divestiture partially offset by favorable volume growth.”

Read it in the 10-K ↗

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K ↗

Work on TECH in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/TECH/export.csv") into a cell.